Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors

Simple item page
dc.contributor.authorQiao, Lixin
dc.contributor.authorChoi, Sungwoon
dc.contributor.authorCase, April
dc.contributor.authorGainer, Thomas G.
dc.contributor.authorSeyb, Kathleen I.
dc.contributor.authorGlicksman, Marcie A.
dc.contributor.authorLo, Donald, C.
dc.contributor.authorStein, Ross L.
dc.contributor.authorCuny, Gregory D.
dc.date.accessioned2020-03-10T17:32:02Z
dc.date.available2020-03-10T17:32:02Z
dc.date.issued2010-11
dc.description.abstractA structure–activity relationship study for a 2-chloroanilide derivative of pyrazolo[1,5-a]pyridine revealed that increased EphB3 kinase inhibitory activity could be accomplished by retaining the 2-chloroanilide and introducing a phenyl or small electron donating substituents to the 5-position of the pyrazolo[1,5-a]pyridine. In addition, replacement of the pyrazolo[1,5-a]pyridine with imidazo[1,2-a]pyridine was well tolerated and resulted in enhanced mouse liver microsome stability. The structure–activity relationship for EphB3 inhibition of both heterocyclic series was similar. Kinase inhibitory activity was also demonstrated for representative analogs in cell culture. An analog (32, LDN-211904) was also profiled for inhibitory activity against a panel of 288 kinases and found to be quite selective for tyrosine kinases. Overall, these studies provide useful molecular probes for examining the in vitro, cellular and potentially in vivo kinase-dependent function of EphB3 receptor.
dc.identifier.citationCopyright 2009 Bioorganic and Medicinal Chemistry Letters. This is a post-print versoin of a published paper that is available at: https://www.sciencedirect.com/science/article/pii/S0960894X09012670. Recommended citation: Qiao, Lixin, Sungwoon Choi, April Case, Thomas G. Gainer, Kathleen Seyb, Marcie A. Glicksman, Donald C. Lo, Ross L. Stein, and Gregory D. Cuny. "Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors." Bioorganic & medicinal chemistry letters 19, no. 21 (2009): 6122-6126. doi: 10.1016/j.bmcl.2009.09.010. This item has been deposited in accordance with publisher copyright and licensing terms and with author's permission.
dc.identifier.urihttps://hdl.handle.net/10657/5971
dc.language.isoen_US
dc.publisherBioorganic and Medicinal Chemistry Letters
dc.subjectstructure-activity relationship
dc.subjectEphB3
dc.subjectKinase
dc.subjectInhibitor
dc.subjectMicrosomal stability
dc.titleStructure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Cuny_2010_Structure-activityrelationshipstudyofEphB3AM.pdf
Size:
820.77 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.69 KB
Format:
Plain Text
Description:
Download

Collections

UH Faculty, Staff, and Student Works